Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision

Published:2022-11 Issue: Volume:110 Page:102444
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Lai Gillianne G.Y.,Guo Robin,Drilon Alexander,Shao Weng Tan Daniel

Funder

Novartis Pharmaceuticals Corporation

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference145 articles.

1. Molecular profiling for precision cancer therapies;Malone;Genome Med,2020

2. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers;Moosavi;Crit Rev Clin Lab Sci,2019

3. Targeting MET dysregulation in cancer;Recondo;Cancer Discov,2020

4. MET exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-Met overexpression;Awad;J Clin Oncol,2016

5. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene;Pennacchietti;Cancer Cell,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal-epithelial transition factor amplification correlates with adverse pathological features and poor clinical outcome in colorectal cancer;World Journal of Gastrointestinal Surgery;2024-05-27

2. The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy;Pharmaceuticals;2024-03-30

3. Gene amplification in neoplasia: A cytogenetic survey of 80 131 cases;Genes, Chromosomes and Cancer;2023-12-05

4. MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing;Drugs and Drug Candidates;2023-07-18

5. Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment;Cancers;2023-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3